Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Vical, Inc.
(NQ:
VICL
)
3.630
USD
UNCHANGED
Official Closing Price
/ Updated:
8:10 PM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
3.600
Bid (Size)
2.780 (400)
Ask (Size)
5.660 (100)
Prev. Close
3.630
Today's Range
3.600 - 3.700
52wk Range
2.610 - 4.740
Shares Outstanding
86,448,194
Dividend Yield
N/A
Top News
More News
Interesting VICL Put And Call For July
May 20, 2013
Investors in Vical, Inc. (VICL) saw new options become available today, for the July expiration.
Read More
category
Stocks
from
Market News Video
Short Interest In Vical, Inc. Moves 21.2% Higher
May 10, 2013
The most recent short interest data has been released by the NASDAQ for the 04/30/2013 settlement date, which shows a 1,304,411 share increase in total short interest for Vical, Inc. (VICL), to...
Read More
category
Stocks
from
Market News Video
More News
Read More
Vical, Inc. (VICL) Reports In-Line Q1 Loss of 11c/Share
May 09, 2013
from
StreetInsider.com News Articles
Vical Reports First Quarter 2013 Financial Results and Progress in Key Development Programs
May 09, 2013
from
GlobeNewswire News Releases
Trading Radar for 05/09: priceline.com (PCLN), NVIDIA (NVDA), DISH Network (DISH), Dean Foods (DF) Report
May 08, 2013
from
StreetInsider.com News Articles
Vical to Present at May Investor Conferences
May 07, 2013
from
GlobeNewswire News Releases
Vical's Vaxfectin Enhances Preclinical Immune Responses to Baxter's Cell Culture-Derived Influenza Vaccines
May 06, 2013
category
Management
,
Benzinga
,
Guidance
, and 3 more.
from
Latest Articles from Benzinga.com
Vical (VICL) Reports Publication of Baxter (BAX) Preclinical Evaluations of Vaxfectin
May 06, 2013
from
StreetInsider.com News Articles
Vaxfectin(R) Enhances Preclinical Immune Responses to Baxter's Cell Culture-Derived Influenza Vaccines
May 06, 2013
from
GlobeNewswire News Releases
Vical Announces News Release and Conference Call Schedule for First Quarter 2013 Financial Results
May 02, 2013
from
GlobeNewswire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here